Skip to main content Accessibility help
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2004
  • Online publication date: December 2009

3 - Assessing health status and quality of life of cancer patients: the use of general instruments



In response to the increasing demand for high quality, affordable health care, policy makers are beginning to consider the burden of disease on patients and their families, as well as on society, more generally.– Within the continuum of cancer care, these concerns are often expressed in terms of health promotion and disease prevention initiatives, evaluations of alternative treatments or other interventions, and provision of compassionate care for survivors of cancer or those living with terminal illness. Traditionally, morbidity and mortality measures have been used for assessing disease and policy impacts, but as more people are living longer, many with chronic disease such as cancer, decision makers are recognizing the need for indicators that inform them not only about quantity of life but also about multiple aspects of quality of life such as physical, social, and mental well-being.

Over the past 30 years, instruments have been developed that provide decision makers with profiles of scores that indicate people's capacity or performance on important domains and subdomains of health status and quality of life. Profiles, rather than a battery of single indicators, have the advantage of using a single scoring system so that domain scores can be easily compared, thereby giving clinicians and policy makers systematic information about well-being and function across the key domains. Generic profiles, such as the Sickness Impact Profile– and the short forms from the Medical Outcomes Study,– are used in demographically and diagnostically diverse populations, whereas general cancer measures, e.g., the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy (FACT-G), have been developed for use across the spectrum of cancer diagnoses.

Brown, M. L., Lipscomb, J., Snyder, C. (2001). The burden of illness of cancer: economic cost and quality of lifeAnnual Review of Public Health 22:91–113
Janknegt, R. (2001). Using health outcomes data to inform decision-making: formulary committee perspectivePharmacoeconomics 19(Suppl. 2):49–52
Lancry, P- J., O'Connor, R., Stempel, al. (2001). Using health outcomes data to inform decision-making: healthcare payer perspectivePharmacoeconomics 19(Suppl. 2):39–47
Taylor, R. (2001). Using health outcomes data to inform decision-making: government agency perspectivePharmacoeconomics 19(Suppl. 2):33–8
Lipscomb, J., Snyder, C. F. (2002). The outcomes of cancer outcomes research: focusing on the National Cancer Institute's Quality-of-Care InitiativeMedical Care 40(Suppl. 6):III3–III10
National Center for Health Statistics (2002). Health, United States, 2002 With Chartbook on Trends in the Health of Americans. Hyattsville, MD: National Center for Health Statistics
Gilson, B. S., Gilson, J. S., Bergner, al. (1975). The Sickness Impact Profile: development of an outcome measure of health careAmerican Journal of Public Health 65(12):1304–10
Bergner, M., Bobbitt, R. A., Carter, W. al. (1981). The Sickness Impact Profile: development and final revision of a health status measureMedical Care 19(8):787–805
Stewart, A. L., Hays, R. D., Ware, J. E. Jr. (1988). The MOS Short-Form General Health Survey: reliability and validity in a patient populationMedical Care 26(7):724–32
Ware, J. E., Sherbourne, C. D.Jr. (1992). The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selectionMedical Care 30(6):473–83
Ware, J. E., Kosinski, M., Keller, S. D. (1996). A 12-Item Short-Form Health Survey (SF-12): Scale Construction and preliminary tests of reliability and validity. Boston, MA: Medical Outcomes Trust
Aaronson, N. K., Ahmedzai, S., Bergman, al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncologyJournal of the National Cancer Institute 85(5):365–76
Cella, D. F., Tulsky, D. S., Gray, al. (1993). The Functional Assessment of Cancer Therapy Scale: development and validation of the general measureJournal of Clinical Oncology 11(3):570–9
Grassi, L., Indelli, M., Marzola, al. (1996). Depressive symptoms and quality of life in home-care-assisted cancer patientsJournal of Pain and Symptom Management 12(5):300–7
Klee, M. C., King, M. T., Machin, al. (2000). A clinical model for quality of life assessment in cancer patients receiving chemotherapyAnnals of Oncology 11(1):23–30
McWhinney, I. R., Bass, M. J., Donner, A. (1994). Evaluation of a palliative care service: problems and pitfallsBritish Medical Journal 309(6965):1340–2
Witteveen, P. O., Jacobs, H. M., Groenestijn, M. A. al. (1999). Assessment of the quality of life of patients with advanced and end-stage cancer or serious infections with a symptom-based or an impact-based instrumentSupportive Care in Cancer 7(2):64–70
Erickson, P., Scott, J. (1993). The On-Line Guide to Quality-of-Life Assessment (OLGA): Resource for Selecting Quality-of-Life Assessments. In Quality of Life Assessment: Key Issues in the 1990s, ed. S. R. Walker, R. M. Rosser, pp. 221–32. Dordrecht, The Netherlands: Kluwer Academic Publishers
Feeny, this volume, Chapter 4
Patrick, D. L., Erickson, P. (1993). Health Status and Health Policy: Quality of Life in Health Care Evaluation and Resource Allocation. New York: Oxford University Press
Erickson, P. (2000). Assessment of the evaluative properties of health status instrumentsMedical Care 38(Suppl. 9):S95–9
Aaronson, this volume, Chapter 20
Snaith, R. P. (1987). The concepts and assessment of depression in oncologyJournal of Psychosocial Oncology 5(3):133–9
Zigmond, A. S., Snaith, R. P. (1983). The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica 67(6):361–70
Maguire, P., Selby, P. (1989). Assessing the quality of life in cancer patients. British Journal of Cancer60:437–40
Nystedt, M., Berglund, G., Bolund, al. (2000). Randomized trial of adjuvant tamoxifen and/or goserelin in premenopausal breast cancer: self-rated physiological effects and symptomsActa Oncologica 39(8):959–68
Howell, S. J., Radford, J. A., Adams, J. al. (2001). Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig Cell Insufficiency following cytotoxic chemotherapyClinical Endocrinology 55(3):315–34
Razavi, D., Kormoss, N., Collard, al. (1999). Comparative study of the efficacy and safety of trazodone versus clorazepate in the treatment of adjustment disorders in cancer patients: a pilot studyJournal of International Medical Research 27(6):264–72
Ranson, M. R., Jayson, G., Perkins, al. (1997). Single-agent paclitaxel in advanced non-small cell lung cancer: single-center phase II study using a 3-hour administration scheduleSeminars in Oncology 24(4 Suppl. 12): 6–9
Smyth, J. F., Bowman, A., Perren, al. (1997). Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trialAnnals of Oncology 8(6):569–73
Bleehen, N. M., Girling, D. J., Hopwood, al. (1996). Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosisBritish Journal of Cancer 73(3):406–13
Joffe, J. K., Banks, R. E., Forbes, M. al. (1996). A Phase II study of interferon-alpha, interleukin-2 and 5-fluorouracil in advanced renal carcinoma: clinical data and laboratory evidence of protease activationBritish Journal of Urology 77(5):638–49
Seymour, M. T., Slevin, M. L., Kerr, D. al. (1996). Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancerJournal of Clinical Oncology 14(8):2280–8
Harper-Wynne, C., English, J., Meyer, al. (1999). Randomized trial to compare the efficacy and toxicity of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with methotrexate mitoxantrone (MM) in advanced carcinoma of the breastBritish Journal of Cancer 81(2):316–22
Hammerlid, E., Mercke, C., Sullivan, al. (1997). A prospective quality of life study of patients with oral or pharyngeal carcinoma treated with external beam irradiation with or without brachytherapyOral Oncology 33(3):189–96
Gregor, A., Cull, A., Stephens, R. al. (1997). Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trialEuropean Journal of Cancer 33(11):1752–8
Griffiths, G. O., Parmar, M. K. B., Bailey, A. J. (1999). Physical and psychological symptoms of quality of life in the CHART randomized trial in head and neck cancer: short-term and long-term patient reported symptomsBritish Journal of Cancer 81(7):1196–205
Gaze, M. N., Kelly, C. G., Kerr, G. al. (1997). Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedulesRadiotherapy and Oncology 45(2):109–16
Hjermstad, M. J., Loge, J. H., Evensen, S. al. (1999). The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantationBone Marrow Transplantation 24(11):1219–28
Loge, J. H., Abrahamsen, A. F., Ekeberg, al. (2000). Fatigue and psychiatric morbidity among Hodgkin's disease survivorsJournal of Pain and Symptom Management 19(2):91–9
Olweny, C. L. M., Juttner, C. A., Rofe, al. (1993). Long-term effects of cancer treatment and consequences of cure: cancer survivors enjoy quality of life similar to their neighboursEuropean Journal of Cancer 29A(6):826–30
Cull, A., Gregor, A., Hopwood, al. (1994). Neurological and cognitive impairment in long-term survivors of small cell lung cancerEuropean Journal of Cancer 30A(8):1067–74
Molassiotis, A., Boughton, B. J., Burgoyne, al. (1995). Comparison of the overall quality of life in 50 long-term survivors of autologous and allogeneic bone marrow transplantationJournal of Advanced Nursing 22:509–16
Stromgren, A. S., Groenvold, M., Pedersen, al. (2001). Does the medical record cover the symptoms experienced by cancer patients receiving palliative care? A comparison of the record and patient self-ratingJournal of Pain and Symptom Management 21(3):189–96
Payne, S. A. (1992). A study of quality of life in cancer patients receiving palliative chemotherapySocial Science and Medicine 35(12):1505–9
Macbeth, F. R., Bolger, J. J., Hopwood, al. (1996). Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance statusClinical Oncology 8(3):167–75
Bratt, O., Damber, J.-E., Emanuelsson, al. (2000). Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancerEuropean Journal of Cancer 36(2):235–41
Brandberg, Y., Bolund, C., Michelson, al. (1993). Psychological reactions in public melanoma screeningEuropean Journal of Cancer 29A(6):860–3
Scaf-Klomp, W., Sanderman, R., Wiel, H. B. al. (1997). Distressed or relieved? Psychological side effects of breast cancer screening in the NetherlandsJournal of Epidemiology and Community Health 51(6):705–10
Brook, R. H., Ware, J. E. Jr., Rodgers, W. al. (1983). Does free care improve adults' health? Results from a randomized controlled trialNew England Journal of Medicine 309(23):1426–34
Tarlov, A. R., Ware, J. E. Jr., Greenfield, al. (1989). The Medical Outcomes Study: an application of methods for monitoring the results of medical careJournal of the American Medical Association 262(7):925–30
Ware, J. E., Sherbourne, C. D., Davies, A. R. (1992). Developing and Testing the MOS 20-Item Short Form Health Survey: A General Population Application. In Measuring Functioning and Well-Being: The Medical Outcomes Study Approach, ed. A. L. Stewart, J. E. Ware, pp. 277–290. Durham, NC: Duke University Press
Ware, J. E., Jr., Snow, K. K., Kosinski, M. et al. (1993). SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: Health Institute
Brandberg, Y., Malm, M., Blomqvist, L. A. (2000). Prospective and randomized study, “SVEA,” comparing effects of three methods for delayed breast reconstruction on quality of life, patient-defined problem areas of life, and the cosmetic resultPlastic and Reconstructive Surgery 105(1):66–74
McGuire, M. S., Grimaldi, G., Grotas, al. (2000). The type of urinary diversion after radical cystectomy significantly impacts on the patient's quality of lifeAnnals of Surgical Oncology 7(1):4–8
Veenstra, K. M., Sprangers, M. A. G.. (2000). Quality of life in survivors with a Van Ness-Borggreve rotationplasty after bone tumour resectionJournal of Surgical Oncology 73(4):192–7
Fujisawa, M., Isotani, S., Gotoh, al. (2000). Health-related quality of life with orthotopic neobladder versus ileal conduit according to the SF-36 surveyUrology 55(6):862–5
Neil-Dwyer, G., Lang, D. A., Davis, A. (2000). Outcome from complex neurosurgery: an evidence-based approachActa Neurochirurgica 142(4):367–71
Naughton, C. K., Miller, D. C., Yan, Y. (2001). Impact of transrectal ultrasound guided prostate biopsy on quality of life: a prospective randomized trial comparing 6 versus 12 coresJournal of Urology 165(1):100–3
Rogers, S. N., Lowe, D., Humphris, G. (2000). Distinct patient groups in oral cancer: a prospective study of perceived health status following primary surgeryOral Oncology 36(6):529–38
Boer, A. G. E. M., Genovesi, Onorbe P. I., Sprangers, M. A. al. (2000). Quality of life in long-term survivors after curative transhiatal oesophagectomy for oesophageal carcinomaBritish Journal of Surgery 87(12):1716–21
Thompson-Fawcett, M. W., Richard, C. S., O'Connor, B. al. (2000). Quality of life is excellent after a pelvic pouch for colitis-associated neoplasiaDiseases of the Colon and Rectum 43(11):1497–502
Clark, P. E., Schover, L. R., Uzzo, R. al. (2001). Quality of life and psychological adaptation after surgical treatment for localized renal cell carcinoma: impact of the amount of remaining renal tissueUrology 57(2):252–6
Davis, A. M., Devlin, M., Griffin, A. al. (1999). Functional outcome in amputation versus limb sparing of patients with lower extremity sarcoma: a matched case-control studyArchives of Physical Medicine and Rehabilitation 80(6):615–18
Janda, M., Gerstner, N., Obermair, al. (2000). Quality of life changes during conformal radiation therapy for prostate carcinomaCancer 89(6):1322–8
Sanchez-Ortiz, R. F., Broderick, G. A., Rovner, E. al. (2000). Erectile function and quality of life after interstitial radiation therapy for prostate cancerInternational Journal of Impotence Research 12(Suppl. 3):S18–24
Beard, C. J., Propert, K. J., Rieker, P. al. (1997). Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes studyJournal of Clinical Oncology 15(1):223–9
Ganz, P. A., Greendale, G. A., Petersen, al. (2000). Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trialJournal of the National Cancer Institute 92(13):1054–64
Hammerlid, E., Taft, C. (2001). Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population normsBritish Journal of Cancer 84(2):149–56
Vickberg, S. M. J., Duhamel, K. N., Smith, M. al. (2001). Global meaning and psychological adjustment among survivors of bone marrow transplantPsycho-Oncology 10(1):29–39
Loge, J. H., Abrahamsen, A. F., Ekeberg, al. (1999). Reduced health-related quality of life among Hodgkin's disease survivors: a comparative study with general population normsAnnals of Oncology 10(1):71–7
Litwin, M. S., Shpall, A. I., Dorey, al. (1998). Quality-of-life outcomes in long-term survivors of advanced prostate cancerAmerican Journal of Clinical Oncology 21(4):327–32
QualityMetrics, Inc. Medical Outcomes Study instruments and measurement tools. Available at: Last accessed October 17, 2002
Hyland, M. E. (2002). Recommendations from quality of life scales are not simple (letter)British Medical Journal 325:599
McNair, D. M., Lorr, M., Droppleman, L. F. (1971/1981). EITS Manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service
Cella, D. F., Jacobsen, P. B., Orav, E. al. (1987). A brief POMS measure of distress for cancer patientsJournal of Chronic Diseases 40(10):939–42
Guadagnoli, E., Mor, V. (1989). Measuring cancer patients' affect: revision and psychometric properties of the Profile of Mood States (POMS)Journal of Consulting and Clinical Psychology 84:907–15
Shacham, S. (1983). A shortened version of the Profile of Mood StatesJournal of Personality Assessment 47(3):305–6
Bunevicius, R., Kazanavicius, G., Zalinkevicius, al. (1999). Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidismNew England Journal of Medicine 340(6):424–9
Postma, T. J., Heimans, J. J., Luykx, S. al. (2000). A phase II study of paclitaxel in chemonaive patients with recurrent high-grade gliomaAnnals of Oncology 11(4):409–43
Ahles, T. A., Silberfarb, P. M., Herndon, J. IIet al. (1998). Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: a study by the Cancer and Leukemia Group BJournal of Clinical Oncology 16(5):1954–60
Heinonen, H., Volin, L., Uutela, al. (2001). Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantationAnnals of Hematology 80(3):137–43
Fife, B. L., Huster, G. A., Cornetta, K. al. (2000). Longitudinal study of adaptation to the stress of bone marrow transplantationJournal of Clinical Oncology 18(7):1539–49
Nissen, M. J., Swenson, K. K., Ritz, L. al. (2001). Quality of life after breast carcinoma surgery: a comparison of three surgical proceduresCancer 91(7):1238–46
Braslis, K. G., Santa-Cruz, C., Brickman, A. al. (1995). Quality of life 12 months after radical prostatectomyBritish Journal of Urology 75(1):48–53
Jason, G. W., Pajurkova, E. M., Taenzer, P. al. (1997). Acute effects on neuropsychological function and quality of life by high-dose multiple daily fractionated radiotherapy for malignant astrocytomas: assessing the tolerability of a new radiotherapy regimenPsycho-Oncology 6(2):151–7
Greenberg, D. B., Kornblith, A. B., Herndon, J. al. (1997). Quality of life for adult leukemia survivors treated on clinical trials of cancer and leukemia Group B during the period 1971–1988: predictors for later psychologic distressCancer 80(10):1936–44
Gotay, C. C., Muraoka, M. Y. (1998). Quality of life in long-term survivors of adult-onset cancersJournal of the National Cancer Institute 90(9):656–67
Haidet, P., Hamel, M. B., Davis, R. al. (1998). Outcomes, preferences for resuscitation, and physician-patient communication among patients with metastatic colorectal cancerAmerican Journal of Medicine 105(3):222–9
Paterson, D. L., Gayowski, T., Wannstedt, C. al. (2000). Quality of life in long-term survivors after liver transplantation: impact of recurrent viral hepatitis C virusHepatitis. Clinical Transplantation 4(1):48–54
Holland, J. C., Silberfarb, P., Tross, S. et al. (1986). Psychosocial research in cancer: the Cancer and Leukemia Group B (CALGB) experience. In Assessment of Quality of Life and Cancer Treatment, ed. V. Ventafridda, F. S. A. M. van Dam, R. Yancik et al., pp. 89–101. New York, NY: Elsevier Science Publishers
Spitzer, W. O., Dobson, A. J., Hall, al. (1981). Measuring the quality of life of cancer patients: a concise QL-Index for use by physiciansJournal of Chronic Diseases 34(12):585–97
Lipton, A., Theriault, R. L., Hortobagyi, G. al. (2000). Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trialsCancer 88(5):1082–90
Berr, F., Wiedmann, M., Tannapfel, al. (2000). Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survivalHepatology 31(2):291–8
Mor, V., Stalker, M. Z., Gralla, al. (1988). Day hospital as an alternative to inpatient care for cancer patients: a random assignment trialJournal of Clinical Epidemiology 41(8):771–85
Leo, E., Audisio, R. A., Belli, F. (1994). Total rectal resection and colo-anal anastomosis for low rectal tumours: comparative results in a group of young and old patientsEuropean Journal of Cancer 30A(8):1092–5
Knight, S. J., Chmiel, J. S., Kuzel, al. (1998). Quality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and criterion related validity of 3 measuresJournal of Urology 160(5):1765–9
Hortobagyi, G. N., Theriault, R. L., Lipton, al. (1998). Long-term prevention of skeletal complications of metastatic breast cancer with pamidronateJournal of Clinical Oncology 16(6):2038–44
Riccardi, A., Tinelli, C., Brugnatelli, al. (2000). Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancerInternational Journal of Oncology 16(4):769–76
Theriault, R. L., Lipton, A., Hortobagyi, G. N. (1999). Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trialJournal of Clinical Oncology 17(3):846–54
Roseveare, C. D., Patel, P., Simmonds, al. (1998). Nutrition and survival in malignant oesophageal stenosis: a randomized controlled trial comparing modified Gianturco Z-Stents with plastic Atkinson tubesEuropean Journal of Gastroenterology and Hepatology 10(8):653–7
Wu, C.-W., Hsieh, M.-C., Lo, Su- al. (1997). Quality of life of patients with gastric adenocarcinoma after curative gastrectomyWorld Journal of Surgery 21(7):777–82
Wu, C.-W., Lo, S.-S., Shen, al. (2000). Surgical mortality, survival, and quality of life after resection for gastric cancer in the elderlyWorld Journal of Surgery 24(4):465–72
Barr, H., Krasner, N., Raouf, al. (1990). Prospective randomized trial of laser therapy only and laser therapy followed by endoscopic intubation for the palliation of malignant dysphagiaGut 31(1):252–8
Donnelly, S., Rybicki, L., Walsh, D. (2001). Quality of life measurement in the palliative management of advanced cancerSupportive Care in Cancer 9(5):361–5
Hinton, J. (1994). Can home care maintain an acceptable quality of life for patients with terminal cancer and their relatives?Palliative Medicine 8(3):183–96
Hinton, J. (1994). Which patients with terminal cancer are admitted from home care?Palliative Medicine 8(3):197–210
Bruin, A. F., Buys, M., Witte, L. al. (1994). The Sickness Impact Profile: SIP68, a short generic version. First evaluation of the reliability and reproducibilityJournal of Clinical Epidemiology 47(8):863–71
Dales, R. E., Belanger, R., Shamji, F. al. (1994). Quality-of-life following thoracotomy for lung cancerJournal of Clinical Epidemiology 47(12):1443–9
Wu, A. W., Damiano, A. M., Lynn, al. (1995). Predicting future functional status for seriously ill hospitalized adults: the SUPPORT prognostic modelAnnals of Internal Medicine 122(5):342–50
Tsevat, J., Cook, E. F., Green, M. al. (1994). Health values of the seriously illAnnals of Internal Medicine 122(7):514–20
Durand-Zaleski, I., Earlam, S., Fordy, al. (1998). Cost-effectiveness of systemic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastasesCancer 83(5):882–8
Earlam, S., Glover, C., Davies, al. (1997). Effect of regional and systemic fluorinated pyrimidine chemotherapy on quality of life in colorectal liver metastasis patientsJournal of Clinical Oncology 15(5):2022–9
Langius, A., Bjorvell, H., Lind, M. G. (1994). Functional status and coping in patients with oral and pharyngeal cancer before and after surgeryHead and Neck 16(6):559–68
Hassan, S. J., Weymuller, E. A. Jr. (1993). Assessment of quality of life in head and neck cancer patientsHead and Neck 15(6):485–96
Tenover, J. L., Pagano, G. A., Morton, A. al. (1997). Efficacy and tolerability of finasteride in symptomatic benign prostatic hyperplasia: a primary care studyClinical Therapeutics 19(2):243–58
McLeod, R. S., Taylor, B. R., O'Connor, B. al. (1995). Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedureAmerican Journal of Surgery 169(1):179–85
Svedlund, J., Sullivan, M., Liedman, al. (1997). Quality of life after gastrectomy for gastric carcinoma: controlled study of reconstructive proceduresWorld Journal of Surgery 21(4):422–33
McDowell, I., Newell, C. (1987). Measuring Health: A Guide to Rating Scales and Questionnaires. New York: Oxford University Press
Patrick, D. L., Deyo, R. (1989). Generic and disease-specific measures in assessing health status and quality of lifeMedical Care 27:S217–23
Ganz, P. A., Schag, C. A. C., Lee, J. al. (1992). The CARES: A generic measure of health-related quality of life for patients with cancerQuality of Life Research 1(1):19–29
Heinrich, R. L., Schag, C. A. C., Ganz, P. A. (1984). Living with cancer: the cancer inventory of problem situationsJournal of Clinical Psychology 40:972–80
Schag, C. A. C., Heinrich, R. L., Ganz, P. A. (1983). Cancer inventory of problem situations: an instrument for assessing cancer patients' rehabilitation needsJournal of Psychosocial Oncology 1:11–24
Ganz, P. A., Schag, C. A. C., Cheng, H.-L. (1990). Assessing the quality of life — a study in newly-diagnosed breast cancer patientsJournal of Clinical Epidemiology 43(1):75–86
Schag, C. A., Heinrich, R. L. (1990). Development of a comprehensive quality of life measurement tool: CARESOncology 4:135–8
Schag, C. A. C., Ganz, P. A., Heinrich, R. L. (1991). Cancer Rehabilitation Evaluation System — Short Form (CARES-SF): a cancer specific rehabilitation and quality of life instrumentCancer 68(6):1406–13
Cramer, J. A., Arrigo, C., Hammee, al. (2000). Comparison between the QOLIE-31 and Derived QOLIE-10 in a clinical trial of levetiracetamEpilepsy Research 41(1):29–38
Devinsky, O., Vickrey, B. G., Cramer, al. (1995). Development of the quality of life in Epilepsy InventoryEpilepsia 36(11):1089–104
Frost, M. H., Suman, V. J., Rummans, T. al. (2000). Physical, psychological and social well-being of women with breast cancer: the influence of disease phasePsycho-Oncology 9(3):221–31
Herth, K. (2000). Enhancing hope in people with a first recurrence of cancerJournal of Advanced Nursing 32(6):1431–41
Rustoen, T., Wiklund, I., Hanestad, B. al. (1998). Nursing intervention to increase hope and quality of life in newly diagnosed cancer patientsCancer Nursing 21(4):235–45
Hawighorst-Knapstein, S., Schonefuss, G., Hoffmann, S. al. (1997). Pelvic exenteration: effects of surgery on quality of life and body image — a prospective longitudinal studyGynecologic Oncology 66(3):495–500
Ganz, P. A., Schag, C. A. C., Lee, J. al. (1992). Breast conservation versus mastectomy: is there a difference in psychological adjustment or quality of life in the year after surgery?Cancer 69(7):1729–38
Glimelius, B., Birgegard, G., Hoffman, al. (1992). Improved care of patients with small cell lung cancer: nutritional and quality of life aspectsActa Oncologica 31(8):823–31
Litwin, M. S., Fine, J. T., Dorey, al. (1997). Health related quality of life outcomes in patients treated for metastatic kidney cancer: a pilot studyJournal of Urology 157(5):1608–12
Schag, C. A. C., Ganz, P. A., Wing, D. al. (1994). Quality of life in adult survivors of lung, colon and prostate cancerQuality of Life Research 3:127–41
Wellisch, D. K., Centeno, J., Guzman, al. (1996). Bone marrow transplantation vs. high-dose cytorabine-based consolidation chemotherapy for acute myelogenous leukemia: a long-term follow-up study of quality-of-life measures of survivorsPsychosomatics 37(2):144–54
Ashing-Giwa, K., Ganz, P. A., Petersen, L. (1999). Quality of life of African-American and white long term breast carcinoma survivorsCancer 85(2):418–26
Gritz, E. R., Carmack, C. L., Moor, al. (1999). First year after head and neck cancer: quality of lifeJournal of Clinical Oncology 17(1):352–60
Sprangers, M. A. G., Cull, A., Groenvold, al. (1998). The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overviewQuality of Life Research 7:291–300
Aaronson, N. K., Cull, A. M., Kaasa, S. et al. (1996). The European Organization for Research and Treatment of Cancer (EORTC) modular approach to quality of life assessment in oncology: an update. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 179–89. Philadelphia, PA: Lippincott-Raven Publishers
Bjordal, K., Ahlmer-Elmqvist, M., Tollesson, al. (1994). Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patientsActa Oncologica 33(8):879–85
Borghede, G., Sullivan, M. (1996). Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30Quality of Life Research 5(2):212–22
Detmar, S. B., Aaronson, N. K. (1998). Quality of life assessment in daily clinical oncology practice: a feasibility studyEuropean Journal of Cancer 34(8):1181–6
Macquart-Moulin, G., Viens, P., Palangie, al. (2000). High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment?Journal of Clinical Oncology 18(4):754–64
Morant, R., Bernhard, J., Maibach, al. (2000). Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinomaAnnals of Oncology 11(2):183–8
Rauch, D. P., Maurer, C. A., Aebi, al. (2001). Activity of gemcitabine and continuous infusion fluorouracil in advanced pancreatic cancerOncology 60(1):43–8
Simons, J. P., Aaronson, N. K., Vansteenkiste, J. al. (1996). Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter studyJournal of Clinical Oncology 14(4):1077–84
Hoffman, K., Glimelius, B. (1998). Evaluation of clinical benefit of chemotherapy in patients with upper gastrointestinal cancerActa Oncologica 37(7–8):651–9
Osoba, D., Brada, M., Prados, M. al. (2000). Effect of disease burden on health-related quality of life in patients with malignant gliomasNeuro-Oncology 2(4):221–8
Huan, S. D., Natale, R. B., Stewart, D. al. (2000). Multicenter phase II trial of losoxantrone (DuP-941) in hormone-refractory metastatic prostate cancerClinical Cancer Research 6(4):1333–6
Latreille, J., Pater, J., Johnston, al. (1998). Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapyJournal of Clinical Oncology 16(3):1174–8
Genre, D., Protiere, C., Macquart-Moulin, al. (2002). Quality of life of breast cancer patients receiving high-dose-intensity chemotherapy: impact of length of cyclesSupportive Care in Cancer 10(3):222–30
Greimel, E., Thiel, I., Peintinger, al. (2002). Prospective assessment of quality of life of female cancer patientsGynecologic Oncology 85(1):140–7
Bjordal, K., Mastekaasa, A., Kaasa, S. (1995). Self-reported satisfaction with life and physical health in long-term cancer survivors and a matched control groupEuropean Journal of Cancer: Oral Oncology 31B(5):340–5
Joly, F., Henry-Amar, M., Arveux, al. (1996). Psychosocial sequelae in Hodgkin's disease survivors: a French population-based case-control studyJournal of Clinical Oncology 14(9):2444–53
Holzner, B., Kemmler, G., Kopp, al. (2001). Quality of life in breast cancer patients — not enough attention for long-term survivors?Psychosomatics 42(2):117–23
Norum, J., Wist, E. A. (1996). Quality of life in survivors of Hodgkin's diseaseQuality of Life Research 5(3):367–74
Kallen, K.-J., Hofmann, M. A. K., Timm, al. (2000). Weekly oxaliplatin, high-dose infusional 5-fluorouracil and folinic acid as palliative third-line therapy of advanced colorectal carcinomaZeitschrift für Gastroenterologie 38(2):153–7
Langendijk, J. A., ten Velde, G. P. M., Aaronson, N. al. (2000). Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective sudyInternational Journal of Radiation Oncology Biology and Physics 47(1):149–55
Radbruch, L., Sabatowski, R., Loick, al. (2000). Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphinePalliative Medicine 14(2):111–19
Doyle, C., Crump, M., Pintilie, al. (2001). Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancerJournal of Clinical Oncology 19(5):1266–74
Geels, P., Eisenhauer, E., Bezjak, al. (2000). Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancerJournal of Clinical Oncology 18(12):2395–405
Cella, D. F. (1997). FACIT MANUAL: Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System, Version 4, Evanston, IL: Evanston Northwestern Healthcare and Northwestern University
Esper, P., Pienta, K., Cella, D. (1995). FACT-P: a new instrument for quality of life evaluation in prostate cancer (Abstract)Journal of Urology 153(Suppl. 4):239A
Carter, J. R., Chen, M. D., Fowler, J. al. (1997). The effect of prolonged cycles of chemotherapy on quality of life in gynaecologic cancer patientsJournal of Obstetrics and Gynaecological Research 23(2):197–203
Lutgendorf, S. K., Anderson, B., Rothrock, al. (2000). Quality of life and mood in women receiving extensive chemotherapy for gynecologic cancerCancer 89(6):1402–11
Sehlen, S., Hollenhorst, H., Lenk, al. (2002). Only sociodemographic variables predict quality of life after radiotherapy in patients with head and neck cancerInternational Journal of Radiation Oncology Biology and Physics 52(3):779–83
Krupski, T., Petroni, G. R., Bissonette, E. al. (2000). Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancerUrology 55(5):736–42
Small, E. J., Meyer, M., Marshall, M. al. (2000). Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisoneJournal of Clinical Oncology 18(7):1440–50
Poon, R. T.-P., Fan, S. T., Yu, W. al. (2001). A prospective longitudinal study of quality of life after resection of hepatocellular carcinomaArchives of Surgery 136(6):693–9
Courneya, K. S., Friedenreich, C. M. (1997). Relationship between exercise pattern across the cancer experience and current quality of life in colorectal cancer survivorsJournal of Alternative and Complementary Medicine 3(3):215–26
Schipper, H., Clinch, J., McMurray, al. (1984). Measuring the quality of life of cancer patients: the Functional Living Index — Cancer: development and validationJournal of Clinical Oncology 2(5):472–83
Clinch, J. J. (1996). The Functional Living Index — Cancer: Ten years later. In Quality of Life and Pharmacoeconomics in Clinical Trials (2nd Edition), ed. B. Spilker, pp. 215–25. Philadelphia, PA: Lippincott-Raven Publishers
Remick, S. C., Sedransk, N., Haase, R. al. (2001). Oral combination chemotherapy in conjunction with filgrastim (G-CSF) in the treatment of AIDS-related non-Hodgkin's lymphoma: evaluation of the role of G-CSF; quality-of-life analysis and long-term follow-upAmerican Journal of Hematology 66(3):178–88
Osoba, D. (2000). Health-related quality-of-life assessment in clinical trials of supportive care in oncologySupportive Care in Cancer 8(2):84–8
Schliephake, H., Schmelzeisen, R., Schonweiler, al. (1998). Speech, deglutition and life quality after intraoral tumour resection: a prospective studyInternational Journal of Oral and Maxillofacial Surgery 27(2):99–105
Goss, P. E., Winer, E. P., Tannock, I. al. (1999). Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patientsJournal of Clinical Oncology 17(1):52–63
Goss, P. E., Strasser, K., Marques, al. (2000). Liarozole fumarate (R85246): in the treatment of ER negative, tamoxifen refractory or chemotherapy resistant postmenopausal metastatic breast cancerBreast Cancer Research and Treatment 64(2):177–88
Harvey, J., Cantrell, J. Jr., Campbell, al. (2001). Mitoxantrone and paclitaxel combination chemotherapy in metastatic breast cancerCancer Investigation 19(3):225–33
Goss, P. E., Oza, A., Goel, al. (2000). Liarozole fumarate (R85246): a novel imidazole in the treatment of receptor positive postmenopausal metastatic breast cancerBreast Cancer Research and Treatment 59(1):55–68
Laufman, L. R., Bukowski, R. M., Collier, M. al. (1993). A randomized, double-blind trial of fluorouracil plus placebo versus fluorouracil plus oral leucovorin in patients with metastatic colorectal cancerJournal of Clinical Oncology 11(10):1888–93
Clohisy, D. R., Le, C. T., Cheng, E. al. (2000). Evaluation of the feasibility of and results of measuring health-status changes in patients undergoing surgical treatment for skeletal metastasesJournal of Orthopaedic Research 18(1):1
Ruckdeschel, J. C., Piantadosi, S. (1994). Quality of life in lung cancer surgical adjuvant trialsChest 106(Suppl. 6):324S–8S
Haes, J. C. J. M., Pruyn, J. F. A., Knippenberg, F. C. E. (1983). Complaint list for cancer patients: first experiencesNederlands Tijdschrift voor de Psychologie 38:403–22
Haes, J. C. J. M., Knippenberg, F. C. E., Neijt, J. P. (1990). Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom ChecklistBritish Journal of Cancer 62(6):1034–8
Luteijn, F., Kok, A. R., Hamel, L. al. (1979). Enige Ervaringe met en KlachtenlijstNederlandsTidjschrift voor Psychologie 34:167
Linssen, A. C. G., Dam, F. S. A. M., Engelsman, al. (1979). Leven met cytostaticaPharmaceutisch Weekblad 114:501
McCorkle, R., Young, K. (1978). Development of a symptom distress scaleCancer Nursing 1(5):373–8
O'Hanlon, D. M., Harkin, M., Karat, al. (1995). Quality-of-life assessment in patients undergoing treatment for oesophageal carcinomaBritish Journal of Surgery 82(12):1682–5
Allen-Mersh, T. G., Earlam, S., Fordy, al. (1994). Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastasesLancet 344(8932):1255–60
Kramer, J. A., Curran, D., Piccart, al. (2000). Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom ChecklistEuropean Journal of Cancer 36(12):1488–97
Kramer, J. A., Curran, D., Piccart, al. (2000). Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancerEuropean Journal of Cancer 36(12):1498–506
Ranson, M., Davidson, N., Nicolson, al. (2000). Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancerJournal of the National Cancer Institute 92(13):1074–80
Haes, J. C. J. M., Olschewski, M. (1998). Quality of life assessment in a cross-cultural context: use of the Rotterdam Symptom Checklist in a multinational randomised trial comparing CMF and Zoladex (Goserlin) treatment in early breast cancerAnnals of Oncology 9(7):745–50
Erickson, P. (2001). Trends in population-based health-related quality of life: implications for interpretation of changeValue in Health 4(6):418
Johnston, M., Pollard, B., Hennessey, P. (2000). Construct validation of the Hospital Anxiety and Depression Scale with clinical populationsJournal of Psychosomatic Research 48(6):579–84
Velikova, G., Wright, P., Smith, A. al. (2001). Self-reported quality of life of individual cancer patients: concordance of results with disease course and medical recordsJournal of Clinical Oncology 19(7):2064–73
Hopwood, P., Howell, A., Maguire, P. (1991). Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnairesBritish Journal of Cancer 64:353–6
Skarstein, J., Aass, N., Fossa, S. al. (2000). Anxiety and depression in cancer patients: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life QuestionnaireJournal of Psychosomatic Research 49(1):27–34
Curran, S. L., Andrykowski, M. A., Studts, J. L. (1995). Short Form of the Profile of Mood States (POMS-SF): psychometric informationPsychological Assessment 7(1):80–3
Mosconi, P., Cifani, S., Crispino, al. (2000). The performance of the SF-36 Health Survey in patients with laryngeal cancerHead and Neck 22(2):175–82
Rogers, S. N., Lowe, D., Brown, J. al. (1998). Comparison between the University of Washington Head and Neck Disease-Specific Measure and the Medical Short Form 36, EORTC-QLQ-C33, and EORTC Head and Neck 35Oral Oncology 34(5):361–72
McHorney, C. A., Ware, J. E., Raczek, A. E. (1993). The MOS 36-Item Short-Form Health Status Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructsMedical Care 31(3):247–63
McHorney, C. A., Ware, J. E., Lu, J. F. al. (1994). The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions and reliability across diverse patient groupsMedical Care 32(4):40–66
Ware, J. E., Kosinski, M., Bayliss, M. al. (1995). Comparison of methods for the scoring and statistical analysis of the SF-36 health profile and summary measures: results from the Medical Outcomes StudyMedical Care 33:A5264–A5279
Stewart, A. L., Greenfield, S., Hays, R. al.(1989) Functional status and well-being of patients with chronic conditions: results from the Medical Outcomes StudyJournal of the American Medical Association 262(7):907–13
Quality Metric, Inc. includes an online version of the instrument, annotated bibliography, on-line article searches, norms table downloads, open discussion groups, FAQs, and weekly SF e-mail newsletters. Available at Last accessed September 9, 2004
Sloan, J. A., Loprinzi, C. L., Kuross, S. al. (1998). Randomized comparison of four tools measuring overall quality of life in patients with advanced cancerJournal of Clinical Oncology 16(11):3662–73
Bergner, M., Bobbitt, R. A., Pollard, W. al. (1976). The Sickness Impact Profile: validation of a Health Status MeasureMedical Care 14(1):57–67
Carter, W. B., Bobbitt, R. A., Bergner, al. (1976). Validation of an interval scaling: the Sickness Impact ProfileHealth Services Research 11(4):516–28
Pollard, W. E. M., Bobbitt, R. A., Bergner, al. (1976). The Sickness Impact Profile: reliability of a health status measureMedical Care 14(2):146–55
Hunt, S. M., McKenna, S. P., McEwen, J. (1981). Reliability of a population survey tool for measuring perceived health problems: a study of patients with osteoarthrosisJournal of Epidemiology and Community Health 35:297–300
Hunt, S. M., McKenna, S. P., McEwen, al. (1980). A quantitative approach to perceived health status: a validation studyJournal of Epidemiology and Community Health 34(4):281–6
McKenna, S. P., McEwen, J., Hunt, S. al. (1984). Changes in the perceived health of patients recovering from fracturesPublic Health (London) 98:97–102
Uyl-de Groot, C. A., Hagenbeek, A., Verdonck, L. al. (1995). Cost-effectiveness of ABMT in comparison with CHOP chemotherapy in patients with intermediate- and high-grade malignant non-Hodgkin's lymphoma (NHL)Bone Marrow Transplantation 16(3):463–70
O'Toole, D., Ducreux, M., Bommelaer, G. al. (2000). Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and toleranceCancer 88(4):770–6
Hunt, S. M., McEwen, J. (1980). The development of a subjective health indicatorSociology of Health and Illness 2:231–46
Hunt, S. M., McEwen, J., McKenna, S. al. (1984). Subjective health assessments and the perceived outcome of minor surgeryJournal of Psychosomatic Research 28(2):105–14
Hunt, S. M., McEwen, J., McKenna, S. al. (1982). Subjective health status of patients with peripheral vascular diseasePractitioner 226(1363):133–6
Ferrans, C. E., Powers, M. J. (1985). Quality of Life Index: development and psychometric propertiesAdvances in Nursing Science 8(1):15–24
Ferrans, C. E., Powers, M. J. (1992). Psychometric assessment of the Quality of Life IndexResearch in Nursing and Health 15(1):29–38
Ferrans, C. E. (1990). Development of a quality of life index for patients with cancerOncology Nursing Forum 17(3 Suppl.):15–21
Schag, C. A. C., Heinrich, R. L., Aadland, R. al. (1990). Assessing problems of cancer patients: psychometric properties of the Cancer Inventory of Problem SituationsHealth Psychology 9(1):83–102
Schag, C. A. C., Ganz, P. A., Polinsky, M. al. (1993). Characteristics of women at risk for psychosocial distress in the year after breast cancerJournal of Clinical Oncology 11(4):783–93
Schag, C. A. C., Heinrich, R. L. (1989). The Cancer Rehabilitation Evaluation System (CARES) Manual. Los Angeles: CARES Consultants
Kemmler, G., Holzner, B., Kopp, M. et al. (1999). Comparison of two quality-of-life instruments for cancer patients: the Functional Assessment of Cancer Therapy-General and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30. Journal of Clinical Oncology17(9):2932–40
Weitzner, M. A., Meyers, C. A., Gelke, C. al. (1995). The Functional Assessment of Cancer Therapy (FACT) Scale: development of a brain subscale and revalidation of the General version (FACT-G) in patients with primary brain tumorsCancer 75(5):1151–61
Winstead-Fry, P., Schultz, A. (1997). Psychometric analysis of the Functional Assessment of Cancer Therapy-General (FACT-G) Scale in a rural sampleCancer 79(12):2446–52
Dow, K. H., Ferrell, B. R., Anello, C. (1997). Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapyThyroid 7(4):613–19
Knight, S. J., Chmiel, J. S., Sharp, L. al. (2001). Spouse ratings of quality of life in patients with metastatic prostate cancer of lower socioeconomic status: an assessment of feasibility, reliability, and validityUrology 57(2):275–80
Morrow, G. R., Lindke, J., Black, P. (1992). Measurement of quality of life in patients: psychometric analyses of the Functional Living Index-Cancer (FLIC)Quality of Life Research 1:287–96
Butow, P., Coates, A., Dunn, al. (1991). On the receiving end. IV: Validation of quality of life indicatorsAnnals of Oncology 2(8):597–603
King, M. T., Dobson, A. J., Harnett, P. R. (1996). A comparison of two quality-of-life questionnaires for cancer clinical trials: the Functional Living Index-Cancer (FLIC) and the Quality of Life Questionnaire Core Module (QLQ-C30)Journal of Clinical Epidemiology 49(1):21–9
Buxton, J., White, M., Osoba, D. (1998). Patients' experiences using a computerized program with a touch-sensitive video monitor for the assessment of health-related quality of lifeQuality of Life Research 7(6):513–19
Osoba, D., Zee, B., Pater, al. (1994). Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancerQuality of Life Research 3(5):353–64
Hjermstad, M. J., Fossa, S. D., Bjordal, al. (1995). Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life QuestionnaireJournal of Clinical Oncology 13(5):1249–54
Bjordal, K., Kaasa, S. (1992). Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-Item Version, and a diagnosis-specific module for head and neck cancer patientsActa Oncologica 31(3):311–21
Niezgoda, H. E., Pater, J. L. (1993). A validation study of the domains of the Core EORTC Quality of Life QuestionnaireQuality of Life Research 2(5):319–25
Ringdal, G. I., Ringdal, K. (1993). Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnosesQuality of Life Research 2:129–40
Apolone, G., Filberti, A., Cifani, al. (1998). Evaluation of the EORTC QLQ-C30 Questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patientsAnnals of Oncology 9(5):549–57
Groenvold, M., Klee, M. C., Sprangers, M. A. al. (1997). Validation of the EORTC QLQ-C30 Quality of Life Questionnaire through combined qualitative and quantitative assessment of patient-observer agreementJournal of Clinical Epidemiology 50(4):441–50
Ravaioli, A., Buda, P., Fava, al. (1996). Assessment of the RSCL quality of life instrument during chemotherapy in an Italian settingQuality of Life Research 5(5):491–5